Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted beta-emitting radionuclide therapies in metastatic castration-resistant prostate cancer

BACKGROUND: Prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) has demonstrated efficacy and tolerability with a dose-response effect in phase I/II trials in men with metastatic castration-resistant prostate cancer (mCRPC). The need for positive PSMA imaging prior to PSMA-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Prostate
Autores principales: Vlachostergios, Panagiotis J., Niaz, Muhammad Junaid, Skafida, Myrto, Mosallaie, Seyed Ali, Thomas, Charlene, Christos, Paul J., Osborne, Joseph R., Molina, Ana M., Nanus, David M., Bander, Neil Harrison, Tagawa, Scott T.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904644/
https://ncbi.nlm.nih.gov/pubmed/33465252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.24104
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares